5-90776485-C-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_032119.4(ADGRV1):c.12436C>T(p.Arg4146*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,612,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R4146R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_032119.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2CInheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- febrile seizures, familial, 4Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152044Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 248304 AF XY: 0.00
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460762Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 726670 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152044Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74248 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Usher syndrome type 2C Pathogenic:1
The c.12436C>T (p.Arg4146*) nonsense variant in the GPR98 (also referred to as ADGRV1) gene is a novel variant that has not previously been reported. Loss of function variants in this gene are a known mechanism, and variants that predict premature protein truncation that are downstream of this c.1236C>T variant have been reported in affected individuals (Stabej PLQ et al . 2012; Garcia-Garcia G et al., 2013) . This variant is absent from the population databases (Exome Sequencing Project = NA; 1000 Genomes = NA; and ExAC = NA). Therefore, this collective evidence supports the classification of the c.12436C>T (p.Arg4146*) as a Likely pathogenic variant for Usher Syndrome Type IIC. We have confirmed this finding in our laboratory using Sanger sequencing. -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg4146*) in the ADGRV1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ADGRV1 are known to be pathogenic (PMID: 19357117, 22135276, 22147658, 26226137, 30718709, 31047384, 32467589). This variant is present in population databases (rs369793306, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with ADGRV1-related conditions. ClinVar contains an entry for this variant (Variation ID: 375405). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at